Introduction
The interest in studying anti-neutrophil cytoplasmic antibodies (ANCA) emerged in the 1960s, together with the discovery of auto-antibodies detection techniques by indirect immunofluorescence [1] . However, only in the 1980s ANCA started to be used for diagnosis and followup of Wegener's granulomatosis (WG) [1] . Classically, there are two major immunofluorescence staining patterns: (1) c-ANCA, a cytoplasmic predominant one, which correlates with the presence of antibodies against proteinase 3 (PR3) and (2) a perinuclear predominant staining pattern, p-ANCA, which correlates with antibodies directed against other proteins, particularly, myeloperoxidase (MPO). Until recently, ANCA, especially c-ANCA, were thought to be exclusively associated with granulomatous vasculitic syndromes, especially, WG. However, their presence has been demonstrated in other diseases, such as rheumathoid arthritis [2, 3] , systemic lupus erythematosus [4] , inflammatory bowel disease [5] , occupational exposure to silica [6] , HIV infection [7] , subacute bacterial endocarditis [8] , and leprosy [9, 10] , suggesting that ANCA could not be so specific for WG as previously thought.
The aim of the present study was to determine the prevalence of ANCA in patients with leprosy in reactive phase, when there is a hyperactivity of the immune system with high production of cytokines and polyclonal activation of B lymphocytes.
Material and methods
We studied patients with leprosy, classified according to Ridley and Jopling criteria [11] , confirmed by bacilloscopy and/or skin biopsy from the Ambulatório de Hanseníase do Hospital Universitário Professor Edgar Santos. Patients with concomitant autoimmune disease were excluded from the study. We included only patients with lepra reaction type 1 or 2, according to the criteria published elsewhere [12] . ANCA were determined by indirect immunofluorescence (IIF) using a commercially available kit (QUANTA Lite ANCA-INOVA) following the protocol summarized below:
The sera to be tested were diluted 1:20 in phosphatebuffered saline (PBS) and incubated on the slides for 30 min in a moist chamber; after this period, the slides were washed with PBS. Again, the slides were incubated in the moist chamber for 30 min, this time with an anti-human IgG conjugate (goat). After washing with PBS, the slides were examined in a fluorescence microscope.
We also tested the sera for the presence of antinuclear antibodies (ANA) by IIF in HEp-2, using a commercially available kit (INOVA).
Results
Twenty patients were included in the study, 9 women and 11 men, with a mean age of 36.9±18.2 years. Half of the patients had lepromatous leprosy (LL) reaction type 2; 37.5% had borderline leprosy (BL), 80% of them had type 1 and 20% had Type 2 reaction; The remaining had tuberculoid leprosy (TL) type 1 reaction. Four patients could not be properly classified. The demographic data and clinical features of the patients are shown in Table 1 .
ANCA were present in only one patient, with a perinuclear staining pattern (p-ANCA). No patient had ANA detected in serum.
Discussion
Leprosy is a chronic infectious disease caused by M. leprae. Brazil has the second highest prevalence of leprosy in the world, being responsible for 94% of the cases diagnosed in the Americas [13] . Prevalence rates vary considerably within the country. About 53% of registered cases come from the North and North eastern regions, as do 40% of new cases, according to World Health Organization data. All patients in our study came from Bahia, a state located in the North eastern region of Brazil.
There is a polyclonal activation of B cells in lepromatous leprosy that results in elevated production of different autoantibodies, including rheumatoid factor (RF), ANA, and ANCA [2, 3] .
Medina et al. [3] studied 64 patients with LL, TL, and BL. They concluded that ANCA may be detected in leprosy, especially p-ANCA, as they reported eight patients with p-ANCA and two patients with c-ANCA, but there was not any association with disease activity or ANCA titers. Freire et al. [14] studied 59 patients with various forms of leprosy and 60 normal individuals. They detected an atypical staining pattern of immunofluorescence (a-ANCA) in 28% of the leprosy patients. No significant correlation with duration of the disease or activity was demonstrated.
More recently, Pradhan et al. [15] searched for the presence of auto-antibodies in 75 patients with LL, BL, and TL and have found c-ANCA in 62.5% of the tested samples, particularly from patients with LL.
Curiously, in our present study, even including only patients with lepra reaction, which, theoretically, would have a higher ANCA positivity because of a hyperactivation of the immune system, we found only one patient with a peri-nuclear staining pattern of ANCA (p-ANCA). Our explanation for such divergence results may rely on the difference in studied populations or, alternatively, methodological differences as the prevalence of ANCA in different clinical situations may also vary depending on the method of cell separation and the experience of the operator. In this regard, we opted by using a well-tested ANCA kit by INOVA.
In conclusion, patients with leprosy in Bahia (Brazil) have a low positivity for c-ANCA. 
